Safety and pharmacokinetics of BR21, a liver-specific CT agent, in healthy volunteers

Acad Radiol. 1998 Apr:5 Suppl 1:S20-2; discussion S28-30. doi: 10.1016/s1076-6332(98)80048-2.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Contrast Media / adverse effects
  • Contrast Media / pharmacokinetics*
  • Humans
  • Iopamidol / adverse effects
  • Iopamidol / analogs & derivatives*
  • Iopamidol / pharmacokinetics
  • Liver / diagnostic imaging*
  • Male
  • Safety
  • Tomography, X-Ray Computed*

Substances

  • Contrast Media
  • iomeprol
  • Iopamidol